Search research articles
Contact Us
Filters
Showing results (831-840 of 839) with videos related to
Page
of 84
Sort By:
You have reached the last page of results.
This site can display upto 839 results.
Nature Communications
|
November 9, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes
Si-Yang Liu, Hua Bao, Qun Wang, et al.
Microbiology Resource Announcements
|
December 12, 2018
Genome Sequences of Nine Erwinia amylovora Bacteriophages
Ruchira Sharma, Jordan A Berg, Nolan J Beatty, et al.
Nature Communications
|
September 8, 2018
Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
Xiaohong Ruby Xu, Yiming Wang, Reheman Adili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
November 7, 2024
Automated real-world data integration improves cancer outcome prediction
Justin Jee, Christopher Fong, Karl Pichotta, et al.
Thoracic Cancer
|
November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer
Dingzhi Huang, Gen Lin, Qian Chu, et al.
Thoracic Cancer
|
January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
Gen Lin, Zhijie Wang, Qian Chu, et al.
Page
of 84
Search research articles
Search
Showing results (831-840 of 839) with videos related to
Sort By:
Page
of 84
You have reached the last page of results.
This site can display upto 839 results.
Nature Communications
|
November 9, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes
Si-Yang Liu, Hua Bao, Qun Wang, et al.
Microbiology Resource Announcements
|
December 12, 2018
Genome Sequences of Nine Erwinia amylovora Bacteriophages
Ruchira Sharma, Jordan A Berg, Nolan J Beatty, et al.
Nature Communications
|
September 8, 2018
Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
Xiaohong Ruby Xu, Yiming Wang, Reheman Adili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
November 7, 2024
Automated real-world data integration improves cancer outcome prediction
Justin Jee, Christopher Fong, Karl Pichotta, et al.
Thoracic Cancer
|
November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer
Dingzhi Huang, Gen Lin, Qian Chu, et al.
Thoracic Cancer
|
January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
Gen Lin, Zhijie Wang, Qian Chu, et al.
Page
of 84